Table 2 Univariate analyses with laboratory parameters in the outcomes in HIV/AIDS patients
Laboratory tests | Death | Discharge | p |
|---|---|---|---|
N = 17 | N = 66 | ||
Hematological data (NVA) | |||
 HIV-RNA copies/mLb | 126,578 (3247–273,012) | 25,258.5 (391.5–145,976.8) | 0.590 |
 Lymphocytes (percent)a (25.0–40.0%) | 20.5 (10.3) | 27.4 (13.5) | 0.055 |
 CD4-T cells/µLb (600 to 1500/mm3) | 44 (7–232) | 79 (30–198.2) | 0.140 |
 CD8-T cells/µLb (200 to 800/mm3) | 402 (198–776) | 544.5 (359.2–1143.8) | 0.312 |
 CD4/CD8 ratiob (1.0 and 4.0) | 0.1 (0–0.4) | 0.1 (0.1–0.3) | 0.123 |
 Hemoglobin (13.0–18.0 g/dL) | 9.3 (2.7) | 10.8 (2.4) | 0.165 |
 Leukocytesb (4500–11,000/mL) | 4740 (3510–8600) | 4215 (3275–5,757.5) | 0.527 |
 Neutrophilsb (1800–7700/mL) | 2660 (1679–3234) | 3118 (2109–4907.5) | 0.113 |
 Monocytesb (80–1100/mL) | 249 (161–379) | 329 (187.2–488.2) | 0.370 |
 Eosinophilsb (40–550/mL) | 2 (2–4) | 4 (2.6–7) | 0.030* |
 Plateletsa (150,000–400,000 × 103/mL) | 299,352.9 (207,630.4) | 273,947.0 (132,454.6) | 0.536 |
 MPVb (8.8 fL to 12.5 fL) | 8.2 (7.8–8.8) | 8.1 (7.4–8.7) | 0.446 |
 PDWb (9.3 fL to 16.0 fL) | 15.8 (13–18.7) | 13.5 (11.2–16.5) | 0.037* |
Biochemistry parameters (NVA) | |||
 Bilirubinb (< 1.0 mg/dL) | 0.4 (0.2–0.9) | 0.4 (0.3–0.7) | 0.999 |
 Creatinineb (0.6–1.35 mg/dL) | 1 (0.7–1.3) | 0.8 (0.6–0.9) | 0.069 |
 LDHb (120 and 246 U/uL) | 435 (332–534) | 367.5 (300.2–474.2) | 0.159 |
 Gamma-glutamyltransferaseb,c | 88 (42–203) | 103.5 (57.8–290) | 0.876 |
 Albuminb (3.5–5.0 g/dL) | 3.4 (2.8–4) | 3.8 (3.3–4.5) | 0.129 |
 Alkaline phosphataseb (65.0–330.0 U/uL) | 282 (200–459) | 281 (201–386) | 0.835 |
 Aspartate aminotransferaseb (2–38.0 U/uL) | 44 (26–82) | 34 (25–58) | 0.280 |
 Alanine aminotransferaseb (2–44.0 U/uL) | 31 (22–41) | 43 (31–77) | 0.038* |